In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
Palpitations – A Practical Approach for Primary Care
Bone Health in Menopausal Women – Is MHT Enough?
Sun-Related Skin Damage – Current Management Options
RSV Vaccination Update
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health